Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Complement Ther Med. 2016 Jul 12;28:13–21. doi: 10.1016/j.ctim.2016.07.001

Table 3.

Changes in metabolic and inflammatory biomarker outcomes in mindfulness and standard group

Mean Change from Baseline (± SD)1

Mindfulness
Group (n=9)
Standard
Group (n=9)
P-value2
Metabolic Biomarkers
HbA1C (%)
   12 weeks 0.27 ± 0.70 −0.12 ± 0.20 0.073
   6 months 0.34 ± 0.38 −0.06 ± 0.31 0.03
Adiponectnin (ug/mL)
   12 weeks −0.10 ± 1.50 0.06 ± 0.69 0.78
   6 months −0.13 ± 1.68 −0.35 ± 0.67 0.73
Inflammatory Biomarkers
Hs-CRP (mg/L)
   12 weeks 0.17 ± 2.80 0.09 ± 0.89 0.743
   6 months 0.12 ± 1.37 0.26 ± 0.57 0.79
IL-6 (pg/ml)
   12 weeks 0.70 ± 2.86 −1.17 ± 5.47 0.673
   6 months 0.26 ± 1.61 −1.08 ± 6.47 0.493
TNF-a (pg/mL)
   12 weeks 0.12 ± 0.22 −0.06 ± 0.29 0.16
   6 months −0.02 ± 0.34 0.09 ± 0.38 0.52
1

Mean changes from baseline calculated as ‘12 week-Baseline’ and ‘6 month-Baseline’.

2

P-values for between-group differences calculated using t-tests for normally distributed differences and the Wilcoxon rank sum test for non-normally distributed differences.

3

Indicates p-value calculated using Wilcoxon-rank sum test. All others calculated using t-test.